Credit Suisse’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-60,000
| Closed | -$5.96M | – | 4484 |
|
|
2019
Q3 | $5.96M | Buy |
60,000
+10,000
| +20% | +$950K | 0.01% | 1620 |
|
|
2019
Q2 | $4.62M | Sell |
50,000
-102,700
| -67% | -$9.75M | ﹤0.01% | 1802 |
|
|
2019
Q1 | $14.4M | Sell |
152,700
-18,300
| -11% | -$1.6M | 0.01% | 1029 |
|
|
2018
Q4 | $11M | Sell |
171,000
-24,700
| -13% | -$1.82M | 0.01% | 1103 |
|
|
2018
Q3 | $17.5M | Buy |
195,700
+60,900
| +45% | +$5.38M | 0.02% | 950 |
|
|
2018
Q2 | $10.7M | Sell |
134,800
-97,500
| -42% | -$8.1M | 0.01% | 1196 |
|
|
2018
Q1 | $20.7M | Sell |
232,300
-19,700
| -8% | -$1.89M | 0.02% | 836 |
|
|
2017
Q4 | $26.3M | Sell |
252,000
-440,300
| -64% | -$49.7M | 0.02% | 743 |
|
|
2017
Q3 | $101M | Buy |
692,300
+235,300
| +51% | +$32.1M | 0.1% | 206 |
|
|
2017
Q2 | $59.4M | Buy |
457,000
+76,200
| +20% | +$9.34M | 0.06% | 338 |
|
|
2017
Q1 | $47.4M | Sell |
380,800
-76,200
| -17% | -$9.12M | 0.04% | 450 |
|
|
2016
Q4 | $52.9M | Buy |
+457,000
| New | +$50.9M | 0.05% | 382 |
|
|
2016
Q3 | – | Sell |
-40,000
| Closed | -$3.94M | – | 4451 |
|
|
2016
Q2 | $3.94M | Hold |
40,000
| – | – | ﹤0.01% | 1805 |
|
|
2016
Q1 | $4M | Buy |
+40,000
| New | +$4.12M | ﹤0.01% | 1693 |
|
|
2015
Q3 | – | Sell |
-6,900
| Closed | -$799K | – | 4760 |
|
|
2015
Q2 | $799K | Sell |
6,900
-30,700
| -82% | -$3.51M | ﹤0.01% | 3374 |
|
|
2015
Q1 | $4.33M | Buy |
+37,600
| New | +$4.49M | ﹤0.01% | 1785 |
|
Other funds holding CELG
Credit Suisse's CELG Position: Q4 2019 in Review
Credit Suisse sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,893,749 shares — an estimated $685M sold.
Credit Suisse first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $685M in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Credit Suisse reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Credit Suisse sold 6,893,749 Celgene Corp shares in Q4 2019, an estimated $685M.
- Credit Suisse first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Credit Suisse's Celgene Corp position peaked at $685M in Q3 2019.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.